Heidelberg Pharma AG (HPHA) Stock Statistics & Valuation Metrics
Total Valuation
Heidelberg Pharma AG has a market cap or net worth of $91.13M. The enterprise value is $152.89M.
- Market Cap
- $91.13M
- Enterprise Value
- $152.89M
Financial Efficiency
Heidelberg Pharma AG’s return on equity (ROE) is 3.87 and return on invested capital (ROIC) is -175.53%.
- Return on Equity (ROE)
- 3.87
- Return on Assets (ROA)
- -1.11
- Return on Invested Capital (ROIC)
- -175.53%
- Return on Capital Employed (ROCE)
- -1.76
- Revenue Per Employee
- 44.16K
- Profits Per Employee
- -1.28M
- Employee Count
- 33
- Asset Turnover
- 0.04
- Inventory Turnover
- 0.25
Valuation Ratios
The current PE Ratio of Heidelberg Pharma AG is -3.30. Heidelberg Pharma AG’s PEG ratio is 0.07.
- PE Ratio
- -3.30
- PS Ratio
- 10.59
- PB Ratio
- -4.91
- Price to FCF
- -5.16
- Price to Operating Cash Flow
- -4.95
- PEG Ratio
- 0.07
Income Statement
In the last 12 months, Heidelberg Pharma AG had revenue of 1.46M and earned -42.28M in profits. Earnings per share was -0.91.
- Revenue
- 1.46M
- Gross Profit
- -1.19M
- Operating Income
- -47.44M
- Pretax Income
- -41.23M
- Net Income
- -42.28M
- EBITDA
- -44.63M
- Earnings Per Share (EPS)
- -0.91
Cash Flow
In the last 12 months, operating cash flow was -19.14M and capital expenditures 28,976, giving a free cash flow of -19.11M billion.
- Operating Cash Flow
- -19.14M
- Free Cash Flow
- -19.11M
- Free Cash Flow per Share
- -0.43
Dividends & Yields
Heidelberg Pharma AG pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -19.36%
- Earnings Yield
- -31.53%
Important Dates
Heidelberg Pharma AG upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Jul 15, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Heidelberg Pharma AG as a current ratio of 2.53, with Debt / Equity ratio of -10.67%
- Current Ratio
- 2.53
- Quick Ratio
- 1.58
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.31
- Interest Coverage Ratio
- -9656.78
Taxes
In the past 12 months, Heidelberg Pharma AG has paid 1.05M in taxes.
- Income Tax
- 1.05M
- Effective Tax Rate
- -0.03
Enterprise Valuation
Heidelberg Pharma AG EV to EBITDA ratio is -2.99, with an EV/FCF ratio of -4.14.
- EV to Sales
- 8.50
- EV to EBITDA
- -2.99
- EV to Free Cash Flow
- -4.14
- EV to Operating Cash Flow
- -4.14
Balance Sheet
Heidelberg Pharma AG has $19.84M in cash and marketable securities with $298.96K in debt, giving a net cash position of $19.54M billion.
- Cash & Marketable Securities
- $19.84M
- Total Debt
- $298.96K
- Net Cash
- $19.54M
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- -$0.63
Margins
Gross margin is 79.52%, with operating margin of -331.50%, and net profit margin of -320.90%.
- Gross Margin
- 79.52%
- Operating Margin
- -331.50%
- Pretax Margin
- -305.07%
- Net Profit Margin
- -320.90%
- EBITDA Margin
- -284.42%
- EBIT Margin
- -309.85%
Scores
- Smart Score
- 8
- AI Score
- ―